ENDOMETRIAL NEOPLASMS
Clinical trials for ENDOMETRIAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL NEOPLASMS trials appear
Sign up with your email to follow new studies for ENDOMETRIAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called LY4175408 in people with advanced lung, endometrial, or triple-negative breast cancers that have not responded to standard treatments. The drug is designed to seek out and attack cancer cells carrying a specific marker (PTK7). The main goals are…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
New radiation therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment called LY4257496 for people with advanced breast, colorectal, prostate, or endometrial cancer that has spread. The treatment delivers radiation directly to cancer cells that have a specific protein (GRPR). The goal is to see if it is safe and shri…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 28, 2026 13:01 UTC